ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,077, issued on June 17, was assigned to Janssen Vaccines & Prevention B.V. (Leiden, Netherlands).
"Stabilized pre-fusion RSV F proteins" was invented by Johannes Petrus Maria Langedijk (Amsterdam).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are stable pre-fusion respiratory syncytial virus (RSV) F proteins. Also provided are immunogenic compositions comprising RSV F proteins and uses thereof for the prevention and/or treatment of RSV infection. Also provided are nucleic acids encoding the stable pre-fusion RSV F proteins."
The patent was filed on Nov. 12, 2019, under Application No. 17/293,364.
*For further information, including images...